metformin and s 1743

metformin has been researched along with s 1743 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Beard, S; Binder, NK; Brownfoot, FC; Cannon, P; Hannan, NJ; Hastie, R; Kaitu'u-Lino, TJ; Nguyen, TV; Tong, S	1
Bozkuş, Y; Demir, CÇ; İyidir, ÖT; Kırnap, N; Mousa, U; Nar, A; Tütüncü, NB	1

Trials

1 trial(s) available for metformin and s 1743

Article	Year
Short-Term Effect of Hypergastrinemia Following Esomeprazole Treatment On Well-Controlled Type 2 Diabetes Mellitus: A Prospective Study. Endocrine, metabolic & immune disorders drug targets, 2020, Volume: 20, Issue:7 Topics: Aged; Anti-Ulcer Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Esomeprazole; Female; Gastrins; Glycated Hemoglobin; Glycemic Control; Humans; Male; Metformin; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Up-Regulation	2020

Article

Year

Short-Term Effect of Hypergastrinemia Following Esomeprazole Treatment On Well-Controlled Type 2 Diabetes Mellitus: A Prospective Study.

Endocrine, metabolic & immune disorders drug targets, 2020, Volume: 20, Issue:7

Topics: Aged; Anti-Ulcer Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Esomeprazole; Female; Gastrins; Glycated Hemoglobin; Glycemic Control; Humans; Male; Metformin; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Up-Regulation

2020

Other Studies

1 other study(ies) available for metformin and s 1743

Article	Year
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia. PloS one, 2018, Volume: 13, Issue:2 Topics: Endothelium, Vascular; Esomeprazole; Female; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Pre-Eclampsia; Pregnancy; Vascular Endothelial Growth Factor Receptor-1	2018